施罗德在2025年第三季度将其ICU医疗股份增加了25.2%,因为该公司超过了收益估计,但未达到收入目标. Schroder increased its ICU Medical stake by 25.2% in Q3 2025, as the company beat earnings estimates but missed revenue targets.

Schroder投资管理集团在2025年问题3中将ICU Medical(ICUI)的股权增加了25.2%,现在持有796 704股,价值约9 320万美元。 Schroder Investment Management Group boosted its stake in ICU Medical (ICUI) by 25.2% in Q3 2025, now holding 796,704 shares valued at about $93.2 million. 该公司报告,Q4收入为每股191美元,估计损失额为5.3594亿美元,但收入达5.3594亿美元,未达到预期值,逐年下降14.1%。 The company reported Q4 earnings of $1.91 per share, beating estimates, but revenue of $535.94 million missed expectations and dropped 14.1% year-over-year. 医疗中心维持了2026财年每股7.75至8.45美元的收益预期. ICU Medical maintained its fiscal 2026 earnings guidance at $7.75 to $8.45 per share. 分析家按平均目标179.33美元对存货进行“机动购买”评级,而股票交易额约为133.34美元。 Analysts rate the stock a "Moderate Buy" with a $179.33 average target, while the stock trades around $133.34.